• Fund Type: Unit Trust
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

AXA Framlington Biotech Fund

+ Add to Watchlist

FRABIOA:LN

163.10 GBp 3.00 1.87%

As of 00:59:30 ET on 01/26/2015.

Snapshot for AXA Framlington Biotech Fund (FRABIOA)

Year To Date: +9.68% 3-Month: +26.63% 3-Year: +44.10% 52-Week Range: 95.62 - 163.10
1-Month: +8.16% 1-Year: +41.84% 5-Year: +30.65% Beta vs NBI: 0.94

Mutual Fund Chart for FRABIOA

No chart data available.
  • FRABIOA:LN 163.90
  • 1M
  • 1Y
Interactive FRABIOA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FRABIOA

AXA Framlington Biotech Fund is an authorized unit trust incorporated in the United Kingdom. The aim of the Fund is to provide long-term capital appreciation The Fund will invest principally in equity securities of companies in the biotechnology, genomic and medical research industries worldwide.

Inception Date: 11-26-2001 Telephone: 44-207-374-4100
Managers: LINDEN THOMSON / GEMMA GAME
Web Site: www.axa-framlington.com

Fundamentals for FRABIOA

NAV (on 2015-01-26) 163.90
Assets (M) (on 2014-11-27) 477.91
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 100.00

Dividends for FRABIOA

Dividend Type Omitted
Dividend Frequency Semi-Anl
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for FRABIOA

Front Load 5.50
Back Load 0.00
Current Mgmt Fee 1.75
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.95

Top Fund Holdings for FRABIOA

Filing Date: 12/31/2014
Name Position Value % of Total
Biogen Idec Inc 234,180 51,018,800 9.800%
Celgene Corp 659,882 47,374,600 9.100%
Amgen Inc 422,658 43,209,800 8.300%
Gilead Sciences Inc 645,406 39,045,000 7.500%
Vertex Pharmaceuticals Inc 334,564 25,509,400 4.900%
Regeneron Pharmaceuticals Inc 86,997 22,906,400 4.400%
Alexion Pharmaceuticals Inc 192,890 22,906,400 4.400%
Illumina Inc 188,966 22,385,800 4.300%
BioMarin Pharmaceutical Inc 287,132 16,659,200 3.200%
Incyte Corp 332,846 15,618,000 3.000%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil